Double Medical Technology Inc.

Shenzhen Stock Exchange 002901.SZ

Double Medical Technology Inc. Capital Expenditure for the year ending December 31, 2023: USD -43.06 M

Double Medical Technology Inc. Capital Expenditure is USD -43.06 M for the year ending December 31, 2023, a -4.24% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).

Double Medical Technology Inc. Capital Expenditure for the year ending December 31, 2022 was USD -41.31 M, a -11.64% change year over year.
Double Medical Technology Inc. Capital Expenditure for the year ending December 31, 2021 was USD -37.00 M, a -76.13% change year over year.
Double Medical Technology Inc. Capital Expenditure for the year ending December 31, 2020 was USD -21.01 M, a 54.18% change year over year.
Double Medical Technology Inc. Capital Expenditure for the year ending December 31, 2019 was USD -45.85 M, a -205.02% change year over year.

Key data

Date	Capital Expenditure	Free Cash Flow	Depreciation And Amortization	Deferred Income Tax

Shenzhen Stock Exchange: 002901.SZ

Double Medical Technology Inc.

CEO	Mr. Jiong Luo
IPO Date	Sept. 22, 2017
Location	China
Headquarters	No. 18, Shanbianhong East Road
Employees	4,033
Sector	Healthcare
Industries Medical Instruments 3D Printing Automotive Parts Biotechnology Defense & Military Personal Care Plastics Robotics

Description

Double Medical Technology Inc. provides services, technologies, and devices in the areas of orthopedics, wound management, neurosurgery, and general surgery in China. It also exports its products to approximately 50 countries and regions, including European Union, Russia, South America, Australia, Southeast Asia, the Middle East, and South Africa. The company was formerly known as Xiamen Da Bo Ying Jing Medical Equipment Company Limited. Double Medical Technology Inc. was founded in 2004 and is based in Xiamen, the People's Republic of China.

Key trends

Past 5 years